In response to the pandemic, we’ve seen collaboration between life sciences companies that are putting local facilities work to solve the global health crisis. On Monday, Mayor Brandon Scott proposed a new partnership that would make those life-saving products available directly to the city in which they’re made.
In a letter to pharmaceutical company Johnson & Johnson, Scott proposed that 300,000 doses of the company’s COVID-19 vaccine that are manufactured in Baltimore by Maryland-based biotech company Emergent BioSolutions be purchased directly by the City of Baltimore. Scott said the doses can help to ensure that the vaccine is distributed equitably in Baltimore.
“Through its partnership with Emergent BioSolutions, Johnson & Johnson will benefit from the medical expertise and skills of Baltimore City,” Scott wrote. “What we propose is a historic partnership between Johnson & Johnson and the City of Baltimore to not only vaccinate Baltimore City residents, but also tackle the effects of structural racism that have contributed to health disparities.”
READ FULL ARTICLE HERE
